ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Thursday, 2 July 2015

Post-traumatic Stress Disorder Therapeutics Market 2015 Trend, Analysis, and Forecasts to 2019 include new market research report"Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 " to its huge collection of research reports.

About PTSD

PTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of the gender; its symptoms can develop immediately after a traumatic event or during the course of time.

Its symptoms normally include re-experience of the traumatic event, avoidance of the incidents, and abnormal mood swings. Treatments for PTSD include psychological counselling, which help in identifying the cause of the condition and providing counselling to come out of the situation. Medications present in the market help in reducing the symptoms during the course of the treatment.

Technavio's analysts forecast the global PTSD therapeutics market to grow at a CAGR of 1.09% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global PTSD therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic, off-label, and branded therapies used for the treatment of PTSD. This report includes the segmentation of the market based on geography.

Key Regions

Key Vendors
Otsuka Pharmaceutical

Other Prominent Vendors
Azevan Pharmaceuticals
Baylor Research Institute 
Eli Lilly 
Forest Laboratories

H. Lundbeck
Humanetics Pharmaceuticals
Marinus Pharmaceuticals
Neurocrine Biosciences
Novartis Pharmaceuticals
Tonix Pharmaceuticals

Market Driver
Growing Number of Accidents and Violence Worldwide
For a full, detailed list, view our report

Market Challenge
Unavailability of Standard Diagnostic Methods
For a full, detailed list, view our report

Market Trend
Rise in Public Awareness
For a full, detailed list, view our report
All Countrywise Report @

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?


Post a Comment